Image

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Study on Pelacarsen for Black and Hispanic participants with heart disease.

Recruiting
18-80 years
All
Phase 3

This study is for Black/African American and Hispanic people in the U.S. with *ASCVD*, a heart disease problem. We are testing a medicine called **pelacarsen** to see if it can lower a substance in the blood called *Lp(a)*, which can increase heart disease risk. Participants will receive either pelacarsen or a *placebo* (a harmless pill that looks like the real medicine) given as an injection under the skin once a month.

To join the study, you must be between 18 and 80 years old and already taking medicine for heart disease risk factors. You should have high Lp(a) levels and existing heart conditions like coronary heart disease or peripheral artery disease. You can't join if you have uncontrolled high blood pressure, severe heart failure, or other serious health issues.

  • **Study Length:** The study is ongoing, with monthly injections.
  • **Visits Needed:** Regular check-ups to monitor your health and progress.
  • **Risks:** Possible side effects from the medicine or injections.

Consider these points and talk to your doctor to see if participating is right for you.

Study details
    Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

NCT06267560

Novartis Pharmaceuticals

31 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.